Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Individual author index pages

• Rudolf Poledne
• J. A. Hubáček
• V. Staněk
• M. Aschermann
• J. Matoušková
• J. Veselka
• P. Widimský
• R. Cífková
• V. Lánská
• J. Piťha

Other articles of these authors

• Genetics of T2DM and Its Chronic Complications: Are We Any Closer to the Individual Prediction of Genetic Risk?

  D. Galuška, Lucie Dlouhá, J. A. Hubáček, K. Kaňková

  2022, Vol. 68, Issue 5-6, pp. 159-179
• Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery

  Petr Kačer, J. Pirk, V. Lánská, J. A. Hubáček, V. Adámek, T. Červinková, J. Bělohoubek, O. Auzký, V. Adámková

  2020, Vol. 66, Issue 4, pp. 148-153
• Strong Association between APOA5 Gene Polymorphisms and Hypertriglyceridaemic Episodes

  Michal Vrablík, J. A. Hubáček, D. Dlouha, M. Satny, V. Adámková, R. Ceska

  2019, Vol. 65, Issue 4, pp. 188-194
• Can Leukocyte Telomere Length Predict Survival Time in Heart Transplant Recipients over a Minimal Follow-Up of 20 years?

  Dana Dlouhá, V. Vančura, J. Vymětalová, J. A. Hubáček, V. Lánská, I. Málek

  2016, Vol. 62, Issue 5, pp. 188-193
• MTHFR and HFE, but Not Preproghrelin and LBP, Polymorphisms as Risk Factors for All-Cause End-Stage Renal Disease Development

  Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček

  2014, Vol. 60, Issue 2, pp. 83-88
• Genetic Testing in the Management of Relatives of Patients with Hypertrophic Cardiomyopathy

  Pavol Tomašov, M. Minárik, D. Zemánek, P. Čadová, S. Homolová, K. Čurila, M. Pěnička, L. Benešová, B. Belšánová, P. Gregor, J. Veselka

  2014, Vol. 60, Issue 1, pp. 28-34
• Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population

  Jaroslav A. Hubáček, V. Staněk, M. Gebauerová, R. Poledne, M. Aschermann, H. Skalická, J. Matoušková, A. Kruger, M. Pěnička, H. Hrabáková, J. Veselka, P. Hájek, V. Lánská, V. Adámková, J. Piťha

  2012, Vol. 58, Issue 5, pp. 203-208
• Genetic Variants in Haem Oxygenase-1 and Endothelial Nitric Oxide Synthase Influence the Extent and Evolution of Coronary Artery Atherosclerosis

  Aleš Král, T. Kovárník, L. Králík, H. Skalická, J. Horák, G. S. Mintz, J. Uhrová, M. Sonka, A. Wahle, R. Downe, M. Aschermann, P. Martásek, A. Linhart

  2011, Vol. 57, Issue 5, pp. 182-190
• INSIG2 G-102A Promoter Variant Exhibits Context-Dependent Effect on HDL-Cholesterol Levels but Not on BMI in Caucasians

  Jaroslav A. Hubáček, P. Suchánek, V. Lánská, J. Piťha, V. Adámková

  2011, Vol. 57, Issue 4, pp. 170-172
• Polymorphisms in IFN-γ, TNF-α and IL-10 in Patients on Maintenance Haemodialysis

  Silvie Bloudíčková, L. Kuthanová, J. A. Hubáček

  2011, Vol. 57, Issue 1, pp. 30-34
• INSIG2 Promoter Variant, Obesity Markers and Lipid Parameters – No Association in a Large Slavonic Caucasian Population Sample

  Jaroslav A. Hubáček, L. Kuthanová, R. Bohuslavová, V. Adámková, V. Lánská, T. Meitinger, A. Pfeufer

  2010, Vol. 56, Issue 3, pp. 131-134
• Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction

  Jaroslav A. Hubáček, R. Poledne, J. Piťha, M. Aschermann, H. Skalická, V. Staněk

  2009, Vol. 55, Issue 3, pp. 116-118